We are live on
!
Find out more
R.M. Davis Inc Portfolio holdings
AUM
$6.34B
Turnover
7.99%
1-Year Est. Return
29%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+29%
3 Year Est. Return
+85.15%
5 Year Est. Return
+109.05%
10 Year Est. Return
+412.04%
AUM
$1.81B
AUM Growth
+$73.4M
(+4.2%)
Cap. Flow
+$97.3K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
22.51%
Holding
201
New
9
Increased
84
Reduced
79
Closed
9
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$4.39M |
| 2 |
Ametek
AME
|
+$3.85M |
| 3 |
ConocoPhillips
COP
|
+$2.74M |
| 4 |
Stericycle Inc
SRCL
|
+$2.56M |
| 5 |
Phillips 66
PSX
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Valmont Industries
VMI
|
+$12M |
| 2 |
APA Corp
APA
|
+$6.86M |
| 3 |
Tapestry
TPR
|
+$5M |
| 4 |
DRC
DRESSER-RAND GROUP INC
DRC
|
+$3.61M |
| 5 |
Fastenal
FAST
|
+$2.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Technology | 15.74% |
| 3 | Industrials | 12.75% |
| 4 | Consumer Staples | 9.9% |
| 5 | Consumer Discretionary | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Enterprise Products Partners
EPD
$78.9B
| $1.56M | 0.09% |
43,336
+4,218
| +11% | +$156K |
2013 Q2
6 quarters
|
|
102
Pfizer
PFE
$168B
| $1.55M | 0.09% |
52,614
+5,495
| +12% | +$158K |
2013 Q2
6 quarters
|
|
103
Abbott
ABT
$181B
| $1.54M | 0.08% |
34,213
+120
| +0.4% | +$5.23K |
2013 Q2
6 quarters
|
|
104
Coca-Cola
KO
$400B
| $1.5M | 0.08% |
35,494
+4,025
| +13% | +$172K |
2013 Q2
6 quarters
|
|
105
Vulcan Materials
VMC
$33.1B
| $1.47M | 0.08% |
22,425
-50
| -0.2% | -$3.16K |
2013 Q2
6 quarters
|
|
106
iShares Russell Mid-Cap ETF
IWR
$55.9B
| $1.32M | 0.07% |
31,508
-2,504
| -7% | -$102K |
2013 Q2
6 quarters
|
|
107
DELISTED
Du Pont De Nemours E I
DD
| $1.3M | 0.07% |
18,494
+3,277
| +22% | +$219K |
2013 Q2
6 quarters
|
|
108
iShares Russell 2000 ETF
IWM
$76.2B
| $1.29M | 0.07% |
10,797
-213
| -2% | -$24.4K |
2013 Q2
6 quarters
|
|
109
AT&T
T
$162B
| $1.23M | 0.07% |
48,454
+1,849
| +4% | +$48K |
2013 Q2
6 quarters
|
|
110
Kinder Morgan
KMI
$75.7B
| $1.21M | 0.07% |
+28,630
| New | +$1.13M |
2014 Q4
0 quarters
|
|
|
RDS.A
111
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.21M | 0.07% |
19,341
+5,578
| +41% | +$360K |
2013 Q2
6 quarters
|
|
112
Bristol-Myers Squibb
BMY
$124B
| $1.15M | 0.06% |
19,441
+900
| +5% | +$50.8K |
2013 Q2
6 quarters
|
|
113
DELISTED
Kellanova
K
| $1.1M | 0.06% |
17,839
-42
| -0.2% | -$2.52K |
2013 Q2
6 quarters
|
|
114
Verizon
VZ
$186B
| $1.07M | 0.06% |
22,887
+139
| +0.6% | +$6.8K |
2013 Q2
6 quarters
|
|
|
MMP
115
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.01M | 0.06% |
12,273
+250
| +2% | +$20.4K |
2013 Q2
6 quarters
|
|
116
Illinois Tool Works
ITW
$77.3B
| $1M | 0.06% |
10,604
-180
| -2% | -$16.4K |
2013 Q2
6 quarters
|
|
117
Cisco
CSCO
$424B
| $1M | 0.06% |
36,065
-25
| -0.1% | -$645 |
2013 Q2
6 quarters
|
|
118
Prudential Financial
PRU
$39.9B
| $992K | 0.05% |
10,970
-1,117
| -9% | -$96K |
2013 Q2
6 quarters
|
|
119
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $984K | 0.05% |
25,973
+1,858
| +8% | +$71.9K |
2013 Q2
6 quarters
|
|
120
Merck
MRK
$362B
| $897K | 0.05% |
16,548
+2,754
| +20% | +$153K |
2013 Q2
6 quarters
|
|
121
Intel
INTC
$478B
| $874K | 0.05% |
24,075
+564
| +2% | +$19.6K |
2013 Q2
6 quarters
|
|
122
CVS Health
CVS
$118B
| $855K | 0.05% |
8,877
+225
| +3% | +$19.8K |
2013 Q2
6 quarters
|
|
123
Home Depot
HD
$309B
| $802K | 0.04% |
7,642
| – | – |
2013 Q2
6 quarters
|
|
124
J.M. Smucker
SJM
$13.5B
| $795K | 0.04% |
7,871
-2,000
| -20% | -$203K |
2013 Q2
6 quarters
|
|
125
Vanguard Morningstar Small-Cap ETF
VB
$76.7B
| $791K | 0.04% |
6,782
+566
| +9% | +$64.4K |
2013 Q2
6 quarters
|
|
Similar funds
R.M. Davis Inc's Q4 2014 Portfolio in Review
As of Q4 2014, R.M. Davis Inc held 201 positions worth $1.81B, up 4.2% from $1.74B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
R.M. Davis Inc's Q4 2014 filing shows 9 new, 84 increased, 79 reduced and 9 closed positions. Its largest new stake was Kinder Morgan: 28,630 shares worth $1.21M. The largest sale was Valmont Industries, an estimated $12M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- R.M. Davis Inc's largest Q4 2014 buy was Kinder Morgan: 28,630 shares worth $1.21M.
- R.M. Davis Inc added most to Gilead Sciences in Q4 2014, an estimated $4.39M increase.
- R.M. Davis Inc's biggest Q4 2014 reduction was Valmont Industries, cutting an estimated $12M.
- R.M. Davis Inc fully exited DNOW Inc in Q4 2014, selling an estimated $1.18M.
- R.M. Davis Inc's ten largest holdings make up 23% of its $1.81B portfolio in Q4 2014.
- R.M. Davis Inc opened 9 new positions and closed 9 in Q4 2014.
- R.M. Davis Inc's portfolio value rose 4.2% quarter-over-quarter to $1.81B.
Based on R.M. Davis Inc's 13F filing for Q4 2014, filed 23 Jan 2015.